RTT and EMC enter into an exclusive licensing agreement

RTT announced today that it has entered into an exclusive license agreement with well-renowned Erasmus Medical Center in Rotterdam. The EMC is well known for its research in the field of rare thyroid hormone disorders and is established as a global reference center for MCT8 deficiency. Under the agreement, RTT gains the exclusive world-wide rights to all EMC data, IP and know-how within the field of thyroid hormone signalling disorders.

Leave a Reply

Your email address will not be published. Required fields are marked *